share_log

Eiger BioPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Kayne(12.13%),Propel Bio Management LLC(9.91%), etc.

SEC announcement ·  Nov 2, 2023 21:54
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more